The 27th Annual IWMF Educational Forum provides a unique opportunity to learn and connect with and from one another. The 2022 Virtual Ed Forum brings WM specialists, clinicians, researchers, patients, and caregivers together. A two-day program features pertinent and timely information related to symptoms and complications of WM, current treatment options, new therapies, and life topics that align with this year’s Ed Forum theme:  Living, Learning, and Thriving with WM. This year’s Educational Forum will conclude with our popular “Ask the Doctors” question-and-answer session.

A project that has been a long time in the making came to fruition earlier this year.  The goal of the WMFC was to have a series of video conferences led by key WM researchers, and to specifically invite Canadian Medical Professionals to learn more about our disease from those who know it best.

Rare Cancers Updates offers a dynamic half-day online learning experience aimed at helping clinicians efficiently gain valuable education on a rare topic. You'll have the opportunity to earn CME credits and compete for amazing prizes during our 2022 Contest! Join us during the June 17th meeting, where you'll gain insights and practical guidance on Waldenström Macroglobulinemia. Registration is free!

WM patients and caregivers under the age of 50:Join the Young WM International Support Group on May 16th with special guest, Dr. Shayna Sarosiek!

Workshop Date and Time: Wednesday, May 25, 2022, 1:30 – 2:30 pm, Eastern Time. Registrants can listen in live over the phone or online as a webcast. Click below to learn more or register for this workshop.

In this issue of the IWMF Torch, Dr. Jorge Castillo reviews the disgnosis, indications to treat, and treatment options for Bing Neel Syndrome (BNS) in patients with WM, as these have a direct impact on further understanding the choices available to manage BNS.

Our IWMF Support Group Leaders and International Affiliates had the pleasure of meeting with Dr. Shayna Sarosiek of Dana-Farber Cancer Institute this week. Dr. Sarosiek covered many topics, including Evusheld, CAR-T therapy, and WM treatments on the horizon. This is a fabulous and timely presentation you don't want to miss!

When faced with a WM diagnosis, what determines the best treatment for YOU? In this 30-minute webinar, Dr. Jorge Castillo will review key factors that affect treatment decisions, emerging treatment research, and tips for partnering with your healthcare team.

Cancer therapy selection, dosing, administration, and the management of related adverse events can be a complex process that should be handled by an experienced health care team. Clinicians must choose and verify treatment options based on the individual patient; drug dose modifications and supportive care interventions should be administered accordingly. The cancer treatment regimens below may include both U.S. Food and Drug Administration-approved and unapproved indications/regimens. These regimens are provided only to supplement the latest treatment strategies.

This program is designed to provide attendees with essential information that  will help you participate more actively and confidently in decisions about your  Waldenström Macroglobulinemia treatment and survivorship.